F. Grunwald et al., Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study, EUR J NUCL, 26(12), 1999, pp. 1547-1552
Citations number
27
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
The aim of this multicentre study was to evaluate the clinical significance
of fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)
in differentiated thyroid carcinoma and to compare the results with both i
odine-131 whole-body scintigraphy (WBS) and technetium-99m 2-methoxyisobuty
lisonitrile (MIBI) or thallium-201 chloride (Tl) scintigraphy, Whole-body P
ET imaging using FDG was performed in 222 patients: 134 with papillary rumo
urs, 80 with follicular rumours and 8 with mixed-cell type tumours. Finally
, for each case an overall clinical evaluation was done including histology
, cytology, thyroglobulin level, ultrasonography, computed tomography and s
ubsequent clinical course, to allow a comparison with functional imaging re
sults. Sensitivity of FDG-PET was 75% and 85% for the whole patient group (
n=222) and the group with negative radioiodine scan (n=166), respectively.
Specificity was 90% in the whole patient group. Sensitivity and specificity
of WBS were 50% and 99%, respectively. When the results of FDG-PET and WBS
were considered in combination, tumour tissue was missed in only 7%. Sensi
tivity and specificity of MIBI/Tl were 53% and 92%, respectively (n=117). W
e conclude that FDG-PET is a sensitive method in the follow-up of thyroid c
ancer which should be considered in all patients suffering from differentia
ted thyroid cancer with suspected recurrence and/or metastases, and particu
larly in those with elevated thyroglobulin values and negative WBS.